Immuneering Corp (NASDAQ: IMRX) Not A Good Play Anymore?
Immuneering Corp (IMRX) concluded trading on Thursday at a closing price of $1.97, with 8.03 million shares of worth about $15.82 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 16.57% during that period and on December 12, 2024 the price saw a loss […]
